CDK1-IN-6

• UNSPSC Description:

  CDK1-IN-6 (Ligand 3) is a potent CDK1 inhibitor. CDK1-IN-6 has the potential for the research of cancer[1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk1-in-6.html

• Smiles:

  CC1=CC=CC(NC2=CC(C3=CC=NC(N4CCOCC4)=C3)=CC=N2)=C1

• Molecular Weight:

  346.43

• References & Citations:

  [1]Zuokun Lu, et al. Computational design of CDK1 inhibitors with enhanced target affinity and drug-likeness using deep-learning framework. Heliyon, 2024, 10(22).

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported